All publications

Export 162 results:
Author Title Type [ Year(Asc)]
2010
Dunn DT, von Wyl V., Price H., Asboe D.  2010.  The impact of the 0-0 cell on measures of amino acid covariation. AIDS. 24:159-60.
Bansi L, Geretti AM, Dunn DT, Hill T, Green H, Fearnhill E, Gazzard B, Nelson M, Porter K, Phillips AN et al..  2010.  Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART). J Acquir Immune Defic Syndr. 53:633-9.
Chilton DN, Castro H, Lattimore S, Harrison LJ, Fearnhill E, Delpech V, Rice B., Pillay D, Dunn DT.  2010.  HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom. Antivir Ther. 15:985-91.
de Oliveira T, Pillay D, Gifford RJM.  2010.  The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS One. 5:e9311.
Price H., Asboe D, Pozniak A, Gazzard B, Fearnhill E, Pillay D, Dunn DT.  2010.  Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. Antivir Ther. 15:203-11.
Boyd K, Walker S, Dunn DT, Judd A, Pillay D, Menson E, Tudor-Williams G, Gibb DM.  2010.  The Prevalence of Darunavir Associated Mutations in PI-naive and PI-experienced HIV-1 Infected Children in the UK. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.
Harrison LJ, Castro H, Cane P A, Pillay D, Booth C, Phillips AN, Geretti AM, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2010.  The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies, June 2010.
Leigh Brown A, Lycett S, Weinert L, Hughes GJ, Fearnhill E, Dunn DT, UK HIV Drug Resistance Database.  2010.  Analysis of the Degree Distribution of HIV Transmission Networks Inferred from Viral Sequence Data. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.
Weinert L, Hughes GJ, Fearnhill E, Dunn DT, Rambaut A, Leigh Brown A, UK HIV Drug Resistance Database.  2010.  Bayesian Phylogeography of HIV among MSM in the UK Indicates a Few Source Areas of Widespread Infection. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.
2009
Hughes GJ, Fearnhill E, Dunn DT, Lycett S, Rambaut A, Leigh Brown A.  2009.  Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog. 5:e1000590.
Harrison LJ, Dunn DT, Green H, Copas A.  2009.  Modelling the association between patient characteristics and the change over time in a disease measure using observational cohort data. Stat Med. 28:3260-75.
Pond S.LKosakov, Posada D., Stawiski E., Chappey C., Poon A.F, Hughes GJ, Fearnhill E, Gravenor M.B, Leigh Brown A, Frost S.D.  2009.  An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol. 5:e1000581.
Geretti AM, Harrison LJ, Green H, Sabin CA, Hill T, Fearnhill E, Pillay D, Dunn DT.  2009.  Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis. 48:1296-305.
Hue S, Gifford RJM, Dunn DT, Fearnhill E, Pillay D.  2009.  Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals. J Virol. 83:2645-54.
Gupta R.K, Hill A., Sawyer A.W, Cozzi-Lepri A, von Wyl V., Yerly S, Lima V.D, Günthard HF, Gilks C., Pillay D.  2009.  Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. Lancet Infect Dis. 9:409-17.
Geretti AM, Phillips AN, Kaye S, Booth C, Mackie N, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2009.  Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viraemia. 18th International HIV Drug Resistance Workshop, June 2009.
Hue S, Gifford RJM, Dunn DT, Fearnhill E, Pillay D.  2009.  Demonstration of sustained drug-resistant HIV-1 lineages circulating among treatment-naïve individuals. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.
Hughes GJ, Leigh Brown A, Bollback J, Rambaut A, Fearnhill E, Dunn DT, UK Collaborative Group on HIV Drug Resistance.  2009.  Phylodynamic analysis of non-B HIV in the United Kingdom reveals substantial post-immigration transmission but longer intervals between transmissions than for subtype B. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.
Pillay D, Dunn DT.  2009.  The biology, epidemiology and clinical implications of transmitted HIV drug resistant viruses. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.
Price H., Dunn DT, Asboe D, Pozniak A, Gazzard B, Pillay D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2009.  Positive and negative drug selection pressures on the N348I connection domain mutation; new insights from in vivo data. 18th International HIV Drug Resistance Workshop, June 2009.